Hannah Knochelmann

Using Th17 cells researchers make adoptive T-cell transfer therapy viable

Adoptive T-cell transfer therapy has had limited use due to…

11 November 2020 | By Hannah Balfour (European Pharmaceutical Review)

Adoptive T-cell transfer therapy has had limited use due to the time involved in CD8+ T cell expansion, using a different type of T cell researchers were able to shorten this timeline, making the therapy more accessible.